SCHEMBL5465160

SCHEMBL5465160

O=C(O)c1cc(/C=C2\SC(=O)N(Cc3cccc(Oc4ccccc4)c3)C2=O)ccc1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 11/20 0.67
▸ ACP1 P24666 10/20 0.67
▸ PTPN2 P17706 3/20 0.62
▸ PTPRF P10586 2/20 0.62
▸ PTPRB P23467 2/20 0.62
▸ AKR1B1 P15121 3/20 0.60
▸ MEN1 O00255 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ CRHBP P24387 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ CRHR2 Q13324 1/20 0.53
▸ NOD2 Q9HC29 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ NLRP3 Q96P20 1/20 0.52
▸ ENPP2 Q13822 1/20 0.52
▸ PPARG P37231 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5457373 1.00 PTPN1 (0.67) PTPN1ACP1PTPN2PTPRFPTPRB
SCHEMBL5454705 0.91 PTPN1 (0.61) PTPN1ACP1PTPN2PTPRFPTPRB
SCHEMBL5454709 0.91 PTPN1 (0.61) PTPN1ACP1PTPN2PTPRFPTPRB
SCHEMBL5468445 0.83 MEN1 (0.56) PTPN1ACP1PTPN2AKR1B1MEN1
SCHEMBL5468449 0.83 MEN1 (0.56) PTPN1ACP1PTPN2AKR1B1MEN1
SCHEMBL5462986 0.83 PTPN1 (0.65) PTPN1ACP1PTPN2PTPRFPTPRB
SCHEMBL5462991 0.83 PTPN1 (0.65) PTPN1ACP1PTPN2PTPRFPTPRB
SCHEMBL5457238 0.82 PTPN1 (0.72) PTPN1ACP1PTPN2PTPRFPTPRB
SCHEMBL5460570 0.82 PTPN1 (0.74) PTPN1ACP1PTPN2PTPRFPTPRB
SCHEMBL5460575 0.82 PTPN1 (0.74) PTPN1ACP1PTPN2PTPRFPTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276011-A1 Plasminogen Activator Inhibitor-1 Inhibitor INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2007-11-29 — — US disclosed
EP-1666469-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR Institute of Medicinal Molecular Design, Inc. (JP) 2006-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276011-A1 Plasminogen Activator Inhibitor-1 Inhibitor SERPINE1, SERPINC1, SERPINB1 PTPN1 3264/4885ACP1 254/4885PTPN2 4314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback